Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography

被引:10
|
作者
Mukherjee, Pradipta [1 ]
Fukuda, Shinichi [2 ,3 ]
Lukmanto, Donny [3 ]
Yamashita, Toshiharu [4 ]
Okada, Kosuke [5 ]
Makita, Shuichi [1 ]
Abd El-Sadek, Ibrahim [1 ,6 ]
Miyazawa, Arata [7 ]
Zhu, Lida [1 ]
Morishita, Rion [1 ]
Lichtenegger, Antonia [1 ,8 ]
Oshika, Tetsuro [2 ]
Yasuno, Yoshiaki [1 ]
机构
[1] Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki, Japan
[2] Univ Tsukuba, Fac Med, Dept Ophthalmol, Tsukuba, Ibaraki, Japan
[3] Univ Tsukuba, Fac Med, Dept Adv Vis Sci, Tsukuba, Ibaraki, Japan
[4] Univ Tsukuba, Grad Sch Comprehens Human Sci, Lab Regenerat Med & Stem Cell Biol, Tsukuba, Ibaraki, Japan
[5] Univ Tsukuba, Fac Med, Div Med Sci, Tsukuba, Ibaraki, Japan
[6] Damietta Univ, Fac Sci, Dept Phys, Dumyat 34517, Egypt
[7] Sky Technol Inc, Tsukuba, Ibaraki, Japan
[8] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
基金
日本科学技术振兴机构; 奥地利科学基金会; 日本学术振兴会;
关键词
LIPID DROPLETS; NONALCOHOLIC STEATOHEPATITIS; INTRACELLULAR MOTION; HEPATIC-FIBROSIS; CONTRAST; PROGRESSION; MOTILITY; ZONATION; MODELS;
D O I
10.1364/BOE.461433
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Label-free metabolic imaging of non-alcoholic fatty liver disease (NAFLD) mouse liver is demonstrated ex vivo by dynamic optical coherence tomography (OCT). The NAFLD mouse is a methionine choline-deficient (MCD)-diet model, and two mice fed the MCD diet for 1 and 2 weeks are involved in addition to a normal-diet mouse. The dynamic OCT is based on repeating raster scan and logarithmic intensity variance (LIV) analysis that enables volumetric metabolic imaging with a standard-speed (50,000 A-lines/s) OCT system. Metabolic domains associated with lipid droplet accumulation and inflammation are clearly visualized three-dimensionally. Particularly, the normal-diet liver exhibits highly metabolic vessel-like structures of peri-vascular hepatic zones. The 1-week MCD-diet liver shows ring-shaped highly metabolic structures formed with lipid droplets. The 2-week MCD-diet liver exhibits fragmented vessel-like structures associated with inflammation. These results imply that volumetric LIV imaging is useful for visualizing and assessing NAFLD abnormalities.
引用
收藏
页码:4071 / 4086
页数:16
相关论文
共 50 条
  • [41] Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study
    Lallukka, Susanna
    Sadevirta, Sanja
    Kallio, Markus T.
    Luukkonen, Panu K.
    Zhou, You
    Hakkarainen, Antti
    Lundbom, Nina
    Orho-Melanders, Marju
    Yki-Jarvinen, Hannele
    SCIENTIFIC REPORTS, 2017, 7
  • [42] Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD)
    Kani, Ali Hashemi
    Alavian, Seyed Moayed
    Esmaillzadeh, Ahmad
    Adibi, Peyman
    Azadbakht, Leila
    HEPATITIS MONTHLY, 2013, 13 (07)
  • [43] A role for IL-1 inhibitors in the treatment of non-alcoholic fatty liver disease (NAFLD)?
    Tilg, Herbert
    Effenberger, Maria
    Adolph, Timon E.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (02) : 103 - 106
  • [44] Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
    O'Gorman, Philip
    Norris, Suzanne
    BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):
  • [45] High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease
    Friis-Liby, I
    Aldenborg, F
    Jeristad, P
    Rundstörm, K
    Björnsson, E
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (09) : 864 - 869
  • [46] Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
    Katsarou, Angeliki
    Moustakas, Ioannis I.
    Pyrina, Iryna
    Lembessis, Panagiotis
    Koutsilieris, Michael
    Chatzigeorgiou, Antonios
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (17) : 1993 - 2011
  • [47] A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD
    Younossi, Zobair M.
    Stepanova, Maria
    Henry, Linda
    Racila, Andrei
    Lam, Brian
    Pham, Huong T.
    Hunt, Sharon
    LIVER INTERNATIONAL, 2017, 37 (08) : 1209 - 1218
  • [48] Non-Invasive Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) using Ultrasound Image Echogenicity
    Benjamin, Alex
    Zubajlo, Rebecca
    Thomenius, Kai
    Dhyani, Manish
    Kaliannan, Kanakaraju
    Samir, Anthony E.
    Anthony, Brian W.
    2017 39TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2017, : 2920 - 2923
  • [49] Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
    Gallego-Duran, Rocio
    Cerro-Salido, Pablo
    Gomez-Gonzalez, Emilio
    Jesus Pareja, Maria
    Ampuero, Javier
    Carmen Rico, Maria
    Aznar, Rafael
    Vilar-Gomez, Eduardo
    Bugianesi, Elisabetta
    Crespo, Javier
    Jose Gonzalez-Sanchez, Francisco
    Aparcero, Reyes
    Moreno, Inmaculada
    Soto, Susana
    Teresa Arias-Loste, Maria
    Abad, Javier
    Ranchal, Isidora
    Jesus Andrade, Raul
    Luis Calleja, Jose
    Pastrana, Miguel
    Lo Iacono, Oreste
    Romero-Gomez, Manuel
    SCIENTIFIC REPORTS, 2016, 6
  • [50] Relationships between variable time, percentage of food restriction and liver histology: which alternative is the best for non-alcoholic fatty liver disease (NAFLD) prevention?
    Makovicky, Peter
    Tumova, Eva
    Volek, Zdenek
    Makovicky, Pavol
    Sedlacek, Radislav
    HISTOLOGY AND HISTOPATHOLOGY, 2016, 31 (10) : 1123 - 1130